Chatrick Paul

Senior Vice President, US Oncology Business Unit


Chatrick Paul, Head of Oncology Business Unit (OBU), leads his team from AstraZeneca’s Gaithersburg, Maryland hub. He brings over twenty years of diverse and progressive pharmaceutical experience to AstraZeneca, bridging strategy and execution roles at global, regional and country levels across multiple therapeutic areas and geographies.

Prior Experience

Before joining AstraZeneca, Chatrick served as the head of the US Oncology Business Unit at Takeda, where he was responsible for driving profitable growth of the business while advancing progress delivering the Takeda US Oncology strategy and building capabilities needed to meet evolving business needs. Prior to that, Chatrick’s roles at Takeda included Country President and General Manager for Canadian operations and Vice President, Global Marketing for Oncology.

Before Takeda, Chatrick worked at Sanofi and Aventis where he held positions of increasing responsibility in sales, marketing and strategic planning.


  • Master of Science, Biochemistry, Punjab University
  • Master of Business Administration, University of Chicago, Booth School of Business